Literature DB >> 8556514

Genetic diversity in human Fc receptor II for immunoglobulin G: Fc gamma receptor IIA ligand-binding polymorphism.

A F Reilly1, C F Norris, S Surrey, F J Bruchak, E F Rappaport, E Schwartz, S E McKenzie.   

Abstract

Fc gamma receptors, and in particular genetic variation in these receptors, are important in disorders of hose defense, immunohematologic disease, and systemic autoimmune diseases. We investigated the His-Arg (CAT/CGT) polymorphism at codon 131 of the Fc gamma receptor IIA gene, which influences ligand binding by the receptor. Previously, individuals had been classified phenotypically on the basis of differential binding of murine immunoglobulin G1, but the Fc gamma receptor IIA genotype distribution has not been reported. We used selective PCR-based sequence analysis of genomic DNA to determine the distribution in healthy individuals. For African-Americans, the genotype distribution was determined to be A/A (14%), A/G (60%), and G/G (26%); for Caucasian Americans, the distribution was A/A (30%), A/G (51%), and G/G (19%). These data correlate well with phenotypic data. We implemented a nonradioactive single-stranded conformational polymorphism analysis to rapidly identify all three genotypes. The PCR-single-stranded conformational polymorphism analysis method will facilitate studies of the genotype distribution in individuals with disorders of immune function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8556514      PMCID: PMC368380          DOI: 10.1128/cdli.1.6.640-644.1994

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  37 in total

Review 1.  Function and heterogeneity of human Fc receptors for immunoglobulin G.

Authors:  J C Unkeless
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

2.  Molecular basis for a polymorphism involving Fc receptor II on human monocytes.

Authors:  M R Clark; S B Clarkson; P A Ory; N Stollman; I M Goldstein
Journal:  J Immunol       Date:  1989-09-01       Impact factor: 5.422

3.  Defect in the membrane expression of high affinity 72-kD Fc gamma receptors on phagocytic cells in four healthy subjects.

Authors:  J L Ceuppens; M L Baroja; F Van Vaeck; C L Anderson
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

4.  The monoclonal antibody 41H16 detects the Leu 4 responder form of human Fc gamma RII.

Authors:  E J Gosselin; M F Brown; C L Anderson; T F Zipf; P M Guyre
Journal:  J Immunol       Date:  1990-03-01       Impact factor: 5.422

5.  Sequences of complementary DNAs that encode the NA1 and NA2 forms of Fc receptor III on human neutrophils.

Authors:  P A Ory; M R Clark; E E Kwoh; S B Clarkson; I M Goldstein
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

6.  An abnormality of the gene that encodes neutrophil Fc receptor III in a patient with systemic lupus erythematosus.

Authors:  M R Clark; L Liu; S B Clarkson; P A Ory; I M Goldstein
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

7.  Fc-receptor for mouse IgG1 (Fc gamma RII) and antibody-mediated cell clearance in patients treated with Leu2a antibody.

Authors:  S L Wee; R B Colvin; J M Phelan; F I Preffer; T A Reichert; D Berd; A B Cosimi
Journal:  Transplantation       Date:  1989-12       Impact factor: 4.939

8.  Polymorphism in mitogenic effect of IgG1 monoclonal antibodies against T3 antigen on human T cells.

Authors:  W J Tax; H W Willems; P P Reekers; P J Capel; R A Koene
Journal:  Nature       Date:  1983 Aug 4-10       Impact factor: 49.962

9.  Human IgG Fc receptor (hFcRII; CD32) exists as multiple isoforms in macrophages, lymphocytes and IgG-transporting placental epithelium.

Authors:  S G Stuart; N E Simister; S B Clarkson; B M Kacinski; M Shapiro; I Mellman
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

10.  Structure and expression of human IgG FcRII(CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes.

Authors:  D G Brooks; W Q Qiu; A D Luster; J V Ravetch
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Functions of the Fc receptors for immunoglobulin G.

Authors:  B K Flesch; J Neppert
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

Review 2.  Fc receptors as adaptive immunoreceptors.

Authors:  Marc Daëron
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

3.  Human FcγRIIA induces anaphylactic and allergic reactions.

Authors:  Friederike Jönsson; David A Mancardi; Wei Zhao; Yoshihiro Kita; Bruno Iannascoli; Huot Khun; Nico van Rooijen; Takao Shimizu; Lawrence B Schwartz; Marc Daëron; Pierre Bruhns
Journal:  Blood       Date:  2011-12-02       Impact factor: 22.113

4.  Evaluation of human FcgammaRIIA (CD32) and FcgammaRIIIB (CD16) polymorphisms in Caucasians and African-Americans using salivary DNA.

Authors:  R C van Schie; M E Wilson
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

5.  Single-nucleotide polymorphisms and copy number variations of the FCGR2A and FCGR3A genes in healthy Japanese subjects.

Authors:  Hiroyuki Moriya; Katsuhiko Saito; Nuala Helsby; Naomi Hayashi; Shigekazu Sugino; Michiaki Yamakage; Takeru Sawaguchi; Masahiko Takasaki; Masato Takahashi; Nahoko Kurosawa
Journal:  Biomed Rep       Date:  2013-12-06

6.  Association of Fcγ receptor IIB polymorphism with cryptococcal meningitis in HIV-uninfected Chinese patients.

Authors:  Xiu-Ping Hu; Ji-Qin Wu; Li-Ping Zhu; Xuan Wang; Bin Xu; Rui-Ying Wang; Xue-Ting Ou; Xin-Hua Weng
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

7.  Differences in Fcgamma receptor IIa genotypes and IgG subclass pattern of anti-malarial antibodies between sympatric ethnic groups in Mali.

Authors:  Elisabeth Israelsson; Manijeh Vafa; Bakary Maiga; Anna Lysén; Nnaemeka C Iriemenam; Amagana Dolo; Ogobara K Doumbo; Marita Troye-Blomberg; Klavs Berzins
Journal:  Malar J       Date:  2008-09-15       Impact factor: 2.979

8.  Phase II open-label study to assess efficacy and safety of lenalidomide in combination with cetuximab in KRAS-mutant metastatic colorectal cancer.

Authors:  Salvatore Siena; Eric Van Cutsem; Mingyu Li; Ulf Jungnelius; Alfredo Romano; Robert Beck; Katia Bencardino; Maria Elena Elez; Hans Prenen; Mireia Sanchis; Andrea Sartore-Bianchi; Sabine Tejpar; Anita Gandhi; Tao Shi; Josep Tabernero
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

Review 9.  Understanding Fc Receptor Involvement in Inflammatory Diseases: From Mechanisms to New Therapeutic Tools.

Authors:  Sanae Ben Mkaddem; Marc Benhamou; Renato C Monteiro
Journal:  Front Immunol       Date:  2019-04-12       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.